Literature DB >> 23843559

Comparison of three copromicroscopic methods to assess albendazole efficacy against soil-transmitted helminth infections in school-aged children on Pemba Island.

Marco Albonico1, Laura Rinaldi, Sonia Sciascia, Maria E Morgoglione, Monica Piemonte, Maria P Maurelli, Vincenzo Musella, Jürg Utzinger, Said M Ali, Shaali M Ame, Giuseppe Cringoli.   

Abstract

BACKGROUND: The diagnostic accuracy of three faecal egg count techniques (Kato-Katz, McMaster and FLOTAC) to assess albendazole efficacy against soil-transmitted helminth (STH) infections was compared.
METHODS: The study is registered with Current Controlled Trials [identifier: ISRCTN90088840]. During September-November 2009, 304 school-aged children on Pemba Island, Tanzania, were screened and those infected with Ascaris lumbricoides, hookworm or Trichuris trichiura were treated with a single dose of albendazole (400 mg). Twenty-one days post-treatment, children provided a single stool sample which was examined using the same diagnostic methods. All stool samples were divided into two aliquots and one was fixed in 5% formalin and examined using FLOTAC and McMaster approximately 6 months after collection.
RESULTS: Using fresh stool samples, comparable prevalences were demonstrated for the three methods at baseline (90-92.2% for T. trichiura, 41.1-52.8% for hookworm, 32.9-37.2% for A. lumbricoides); FLOTAC was the most sensitive method at baseline and follow-up. Albendazole showed high cure rate (CR) against A. lumbricoides (90-97%), moderate CR against hookworm (63-72%) and very low CR against T. trichiura (6-9%), regardless of the technique used. Egg counts (eggs per gram) at baseline were similar for A. lumbricoides and for hookworm among the three methods, and higher using McMaster and Kato-Katz compared with FLOTAC for T. trichiura. All methods were similar for hookworm and A. lumbricoides egg reduction rate (ERR) estimation, but Kato-Katz indicated a significantly higher ERR than McMaster and FLOTAC for T. trichiura. Preserved stool samples revealed consistently lower FECs at baseline and follow-up for all STHs.
CONCLUSION: Further development and validation of standard protocols for anthelminthic drug efficacy evaluation must be pursued.

Entities:  

Keywords:  Diagnostic accuracy; Drug efficacy; FLOTAC; Kato–Katz; McMaster; Soil-transmitted helminths

Mesh:

Substances:

Year:  2013        PMID: 23843559     DOI: 10.1093/trstmh/trt051

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  20 in total

1.  The Mini-FLOTAC technique for the diagnosis of helminth and protozoan infections in humans and animals.

Authors:  Giuseppe Cringoli; Maria P Maurelli; Bruno Levecke; Antonio Bosco; Jozef Vercruysse; Jürg Utzinger; Laura Rinaldi
Journal:  Nat Protoc       Date:  2017-08-03       Impact factor: 13.491

2.  Immigrants living in an urban milieu with sanitation in Southern Italy: persistence and transmission of intestinal parasites.

Authors:  Luciano Gualdieri; Monica Piemonte; Settimia Alfano; Rita Maffei; Maria Elena Della Pepa; Laura Rinaldi; Marilena Galdiero; Massimiliano Galdiero; Giuseppe Cringoli
Journal:  Parasitol Res       Date:  2015-12-28       Impact factor: 2.289

3.  Recombinase Polymerase Amplification Compared to Real-Time Polymerase Chain Reaction Test for the Detection of Fasciola hepatica in Human Stool.

Authors:  Miguel M Cabada; Jose L Malaga; Alejandro Castellanos-Gonzalez; Kelli A Bagwell; Patrick A Naeger; Hayley K Rogers; Safa Maharsi; Maryann Mbaka; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

4.  Potential drivers for schistosomiasis persistence: Population genetic analyses from a cluster-randomized urogenital schistosomiasis elimination trial across the Zanzibar islands.

Authors:  Tom Pennance; M Inês Neves; Bonnie L Webster; Charlotte M Gower; Stefanie Knopp; Iddi Simba Khamis; Shaali M Ame; Said M Ali; Muriel Rabone; Aidan Emery; Fiona Allan; Mtumweni Ali Muhsin; Khamis Rashid Suleiman; Fatama Kabole; Martin Walker; David Rollinson; Joanne P Webster
Journal:  PLoS Negl Trop Dis       Date:  2022-10-10

5.  Side Benefits of Mass Drug Administration for Lymphatic Filariasis on Strongyloides stercoralis Prevalence on Pemba Island, Tanzania.

Authors:  Beatrice Barda; Marco Albonico; Dora Buonfrate; Shaali M Ame; Said Ali; Benjamin Speich; Jennifer Keiser
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

6.  Kato-Katz and Lumbreras rapid sedimentation test to evaluate helminth prevalence in the setting of a school-based deworming program.

Authors:  Martha Lopez; Maria Luisa Morales; Monisha Konana; Paige Hoyer; Roberto Pineda-Reyes; Arthur Clinton White; Hector Hugo Garcia; Andres Guillermo Lescano; Eduardo Gotuzzo; Miguel Mauricio Cabada
Journal:  Pathog Glob Health       Date:  2016-05       Impact factor: 2.894

Review 7.  Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities.

Authors:  Jason M Norman; Scott A Handley; Herbert W Virgin
Journal:  Gastroenterology       Date:  2014-02-05       Impact factor: 22.682

8.  Does vitamin A supplementation protect schoolchildren from acquiring soil-transmitted helminthiasis? A randomized controlled trial.

Authors:  Hesham M Al-Mekhlafi; Tengku Shahrul Anuar; Ebtesam M Al-Zabedi; Mohamed T Al-Maktari; Mohammed A K Mahdy; Abdulhamid Ahmed; Atiya A Sallam; Wan Ariffin Abdullah; Norhayati Moktar; Johari Surin
Journal:  Parasit Vectors       Date:  2014-08-15       Impact factor: 3.876

9.  The effects of plant cysteine proteinases on the nematode cuticle.

Authors:  Victor S Njom; Tim Winks; Oumu Diallo; Ann Lowe; Jerzy Behnke; Mark J Dickman; Ian Duce; Iain Johnstone; David J Buttle
Journal:  Parasit Vectors       Date:  2021-06-05       Impact factor: 3.876

10.  Anthelmintic drugs for treating ascariasis.

Authors:  Lucieni O Conterno; Marilia D Turchi; Ione Corrêa; Ricardo Augusto Monteiro de Barros Almeida
Journal:  Cochrane Database Syst Rev       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.